[PLX] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -58.23%
YoY- -170.91%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 1,769 4,616 2,686 3,064 26,113 764 1,141 7.57%
PBT -10,736 -5,071 -6,119 -6,837 22 179 0 -
Tax 213 43 202 0 -8,765 20,699 -109 -
NP -10,853 -5,071 -6,119 -6,837 9,642 -13,689 -10,041 1.30%
Tax Rate - - - - 39,840.91% -11,563.69% - -
Total Cost 12,622 9,687 8,805 9,901 16,471 14,453 11,182 2.03%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin -613.51 -109.86 -227.81 -223.14 36.92 -1,791.75 -880.02 -5.83%
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS -0.11 -0.05 -0.07 -0.07 0.11 -0.16 -0.12 -1.43%
EPS Diluted -0.11 -0.05 -0.07 -0.07 0.10 -0.16 -0.12 -1.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.